Monograph
M01AE03 - Ketoprofen |
Propably not porphyrinogenic |
PNP |
Rationale
Probably CYP (2C9?) substrate. No data pointing to CYP-induction Two references consider it (probably) safe.
Chemical description
Caps./supp. 50-200 mg/d. Analgetic and antiflogistic propionic acid derivative. Metabolized (2C9?) in the liver )by conjugation with glucuronic acid. South African list: use with care.
French list: authorized. C.Andersson; patient reports: tolerated (n=1).
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
© NAPOS 2025